cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Catalyst Pharmaceuticals Inc
18 own
33 watching
Current Price
$23.27
$0.01
(0.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,923.86M
52-Week High
52-Week High
24.64000
52-Week Low
52-Week Low
13.28000
Average Volume
Average Volume
0.95M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
9.1246
iconMarket Capitalization1,923.86M
icon52-Week High24.64000
icon52-Week Low13.28000
iconAverage Volume0.95M
iconDividend Yield--
iconP/E Ratio9.1246
What does the Catalyst Pharmaceuticals Inc do?
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing first-in-class medicines that address rare and difficult to treat diseases. Its flagship commercial product is FIRDAPSE (amifampridine) tablets 10 milligrams (mg), approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) for adults and for children ages six to seventeen. The Company is also marketing FYCOMPA (perampanel) CIII as a prescription medication used alone or with other medicines to treat focal onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. Its portfolio also includes AGAMREE (vamorolone) an oral suspension 40 mg/ml for the treatment of Duchenne Muscular Dystrophy (DMD). The vamorolone is a corticosteroid treatment for patients suffering from DMD.
Read More
How much money does Catalyst Pharmaceuticals Inc make?
News & Events about Catalyst Pharmaceuticals Inc.
InvestorPlace
1 year ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Although people might not readily recognize these little-known stocks, they offer surprisingly robust upside potential. The post 7 Little-Known Stocks to Buy Now Before They Become the Next Big Thing appeared first on InvestorPlace...
Globe Newswire
1 year ago
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held today at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera will receive USD 90 million upfront at closing (USD75 million in cash and USD15 million equity investment), an additional USD10...
Globe Newswire
1 year ago
CORAL GABLES, Fla., May 01, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases today announced ...
Benzinga
1 year ago
read more...
Globe Newswire
1 year ago
CORAL GABLES, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases...
Frequently Asked Questions
Frequently Asked Questions
What is Catalyst Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Catalyst Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Catalyst Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Catalyst Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Catalyst Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What percentage is Catalyst Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Catalyst Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$23.27
$0.01
(0.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00